Allianz Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Allianz Asset Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-18,671	Closed	-$628K	–	2444
2014 Q4	$628K	Sell	18,671 -11,801	-39%	-$417K	﹤0.01%	1946
2014 Q3	$1.07M	Buy	30,472 +11,801	+63%	+$405K	﹤0.01%	1648
2014 Q2	$614K	Sell	18,671 -25,382	-58%	-$869K	﹤0.01%	1531
2014 Q1	$1.62M	Sell	44,053 -35,718	-45%	-$1.31M	﹤0.01%	1275
2013 Q4	$3.06M	Buy	79,771 +61,557	+338%	+$1.94M	﹤0.01%	1082
2013 Q3	$499K	Hold	18,214	–	–	﹤0.01%	1527
2013 Q2	$382K	Buy	+18,214	New	+$356K	﹤0.01%	1526

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Allianz Asset Management's WX Position: Q1 2015 in Review

Allianz Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 18,671 shares — an estimated $628K sold.

Allianz Asset Management first reported a position in WX in Q2 2013 and held it in 7 quarters. The position peaked at $3.06M in Q4 2013. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Allianz Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Allianz Asset Management sold 18,671 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $628K.
Allianz Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 7 quarters.
Allianz Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $3.06M in Q4 2013.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Allianz Asset Management's 13F filing for Q1 2015, filed 15 May 2015.